Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Serina Therapeutics ( (SER) ) has issued an announcement.
Serina Therapeutics announced that its Chief Development Officer, Randall Moreadith, MD, PhD, will present at the 3rd Annual LNP Immunogenicity & Toxicity Summit in Boston. The presentation aims to highlight recent advancements and insights in the field, potentially impacting the company’s strategic focus and stakeholder engagement.
More about Serina Therapeutics
YTD Price Performance: -61.30%
Average Trading Volume: 23,015
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $46.59M
Learn more about SER stock on TipRanks’ Stock Analysis page.
Trending Articles
- Shareholder Alert for Zeta Global Holdings Corp. (NYSE:ZETA)
- Class Action Lawsuit Against Toronto-Dominion Bank (NYSE:TD)
- 3 Penny Stocks to Watch Now, 12/12/24
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
